Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Neurofibromatosis 1 × gadolinium compound P760 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neurofibromatosis 1 1

Interventions

Magnetic Resonance Imaging 2 Lamotrigine 2 lorlatinib 1 gadolinium compound P760 1 encorafenib 1 cediranib 1 binimetinib 1 Vitamin D 1 Lovastatin 1 Gadolinium DTPA 1 Fluorodeoxyglucose F18 1 Everolimus 1 Dietary Supplements 1 Cholecalciferol 1 Cetuximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02584413 2019-09-03

Hypotonia and Neurofibromatosis Type 1 (NF1) Glioma

Washington University School of Medicine

Phase NA Terminated

Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡